Who
Sanford S. Zweifach
Director
Company insider
Files Form 4 as: Director, Compugen; Director, Carisma Therapeutics; Director, ESSA Pharma; Director, Anthera Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 17 May 2013
- Last trade
- 29 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN Compugenoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2026filed 30 Jul 2026 | CGEN CompugenBiotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 26 Jun 2024filed 27 Jun 2024 | Carisma Therapeuticsoption or derivative | SEC FORM 4 Code A | —19,350 at $0.00 | filing |
| 25 Mar 2024filed 28 Mar 2024 | ESSA Pharmaoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | Carisma Therapeuticsoption or derivative | SEC FORM 4 Code A | —38,700 at $0.00 | filing |
| 7 Mar 2023filed 9 Mar 2023 | Carisma Therapeuticsoption or derivative | SEC FORM 4 Code A | —184,621 | filing |
| 7 Mar 2023filed 9 Mar 2023 | Carisma Therapeutics | SEC FORM 4 Code A | —413 | filing |
| 29 Jun 2022filed 1 Nov 2022 | ESSA Pharmaoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 11 Dec 2020filed 26 Jan 2021 | ESSA Pharmaoption or derivative | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 11 Dec 2020filed 11 Jan 2021 | ESSA Pharmaoption or derivative | SEC FORM 4 Code A | —16,500 at $0.00 | filing |
| 21 May 2015filed 22 May 2015 | Anthera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —28,846 at $0.00 | filing |
| 30 Dec 2014filed 2 Jan 2015 | Anthera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 13 Jun 2014filed 16 Jun 2014 | Anthera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 17 May 2013filed 20 May 2013 | Anthera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 17 May 2013filed 20 May 2013 | Anthera Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.